| Secondary |
| Drug Use For Unknown Indication |
25.6% |
| Product Used For Unknown Indication |
22.9% |
| Renal Transplant |
6.5% |
| Acute Lymphocytic Leukaemia |
5.5% |
| Sinusitis |
5.5% |
| B-cell Lymphoma |
3.7% |
| Hypertension |
3.5% |
| Pain |
2.7% |
| Asthma |
2.4% |
| Chemotherapy |
2.2% |
| Toothache |
2.2% |
| Multiple Myeloma |
2.0% |
| Premedication |
2.0% |
| Bronchitis |
2.0% |
| Cough |
2.0% |
| Ill-defined Disorder |
2.0% |
| Crohn's Disease |
1.9% |
| Prophylaxis |
1.9% |
| Lung Infection |
1.8% |
| Rheumatoid Arthritis |
1.8% |
|
| Toxic Skin Eruption |
10.6% |
| Vomiting |
7.5% |
| Transplant Rejection |
6.2% |
| Hepatocellular Injury |
5.6% |
| Pancreatitis Acute |
5.6% |
| Cytolytic Hepatitis |
5.0% |
| Diarrhoea |
5.0% |
| Pyrexia |
5.0% |
| Thrombocytopenia |
5.0% |
| Tremor |
5.0% |
| Lung Disorder |
4.3% |
| Memory Impairment |
4.3% |
| Osteonecrosis |
4.3% |
| Rash Maculo-papular |
4.3% |
| Sepsis |
4.3% |
| Tachycardia |
4.3% |
| Febrile Bone Marrow Aplasia |
3.7% |
| Renal Vein Thrombosis |
3.7% |
| Rectal Haemorrhage |
3.1% |
| Urticaria |
3.1% |
|
| Concomitant |
| Drug Use For Unknown Indication |
26.7% |
| Product Used For Unknown Indication |
17.5% |
| Crohn's Disease |
8.3% |
| Renal Transplant |
7.7% |
| Pain |
4.1% |
| Prophylaxis |
4.1% |
| Premedication |
3.8% |
| Hypertension |
3.7% |
| Non-small Cell Lung Cancer |
3.0% |
| Prophylaxis Against Transplant Rejection |
2.9% |
| Rheumatoid Arthritis |
2.3% |
| Hiv Infection |
2.1% |
| Chest Pain |
2.0% |
| Asthma |
2.0% |
| Atrial Fibrillation |
1.9% |
| Bronchitis |
1.9% |
| Breast Cancer |
1.8% |
| Rash |
1.6% |
| Anxiety |
1.4% |
| Insomnia |
1.2% |
|
| Vomiting |
11.4% |
| Thrombocytopenia |
10.6% |
| Pyrexia |
10.4% |
| Renal Failure Acute |
6.3% |
| Urticaria |
6.3% |
| Pulmonary Embolism |
5.4% |
| Weight Decreased |
5.2% |
| General Physical Health Deterioration |
4.9% |
| Febrile Bone Marrow Aplasia |
4.6% |
| Toxic Skin Eruption |
4.4% |
| Pancytopenia |
4.1% |
| Hepatitis |
3.5% |
| Neutropenia |
3.3% |
| Rash |
3.3% |
| Renal Failure |
3.0% |
| Lung Disorder |
2.7% |
| Pleural Effusion |
2.7% |
| Pruritus |
2.7% |
| Somnolence |
2.7% |
| Agranulocytosis |
2.5% |
|
| Interacting |
| Emphysema |
19.0% |
| Bronchitis |
17.7% |
| Lung Disorder |
15.2% |
| Hiv Infection |
11.4% |
| Chronic Obstructive Pulmonary Disease |
5.1% |
| Hypertension |
3.8% |
| Pneumonia Pneumococcal |
3.8% |
| Back Pain |
2.5% |
| Depression |
2.5% |
| Hypercholesterolaemia |
2.5% |
| Parkinsonism |
2.5% |
| Prophylaxis |
2.5% |
| Thrombosis Prophylaxis |
2.5% |
| Antibiotic Prophylaxis |
1.3% |
| Anxiety |
1.3% |
| Arrhythmia |
1.3% |
| Atrial Fibrillation |
1.3% |
| Cerebrovascular Accident |
1.3% |
| Coagulopathy |
1.3% |
| Fungal Infection |
1.3% |
|
| International Normalised Ratio Increased |
18.8% |
| Walking Disability |
18.8% |
| Cushing's Syndrome |
12.5% |
| Rectal Haemorrhage |
12.5% |
| Rhabdomyolysis |
12.5% |
| Tendonitis |
12.5% |
| Muscle Atrophy |
6.3% |
| Synovitis |
6.3% |
|
